MADISON, Wis., Oct. 12, 2020 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the introduction of the Oncotype MAP™ Pan-Cancer Tissue test for patients with advanced, metastatic, ...

Each year, the Department of Elementary and Secondary Education (DESE) releases the results of the Missouri Assessment Program, a standardized test commonly known as the MAP test, which in part ...